<p>Airway resistance curves to methacholine for (A) WT and (B) PHIL mice; (C) Maximal airway resistance in response to 25 mg/mL methacholine <i>i.n.</i> (n = 10 per group). Data are presented as the maximal resistance between 3.1–25 mg/mL minus the baseline value (0 mg/ml) for each mouse. In WT and PHIL mice, there was a significant increase in methacholine airway responsiveness in HDM versus SAL in WT and PHIL mice. This was significantly attenuated by treatment with AMD3100. Data are expressed as mean ± SEM. *p<0.05 compared with SAL; #p<0.05 compared with HDM.</p
<p>(A) Lung sections stained with periodic acid-Schiff (PAS) and elastic van Gieson's (EVG) stains. ...
<p>After last OVA challenge, mice were exposed to a series of incremental dosages of methacholine (6...
<p>WT or JH<sup>-/-</sup> mice were intranasally exposed to OAAH or PBS for 2 weeks, as described in...
<p>The airway resistance (R), after increasing concentrations of methacholine (0–10 mg/ml), was meas...
<p>Mice with OVA-induced EAB (EAB-Mice), with/without treatment with sPLA<sub>2</sub> inhibitor (EAB...
<p>(A) Log<sub>2</sub>(Penh) response curve to increasing doses of methacholine in A/J, C57BL/6J, Bc...
a<p>Inhalation, <sup>b</sup> Intranasal</p>*<p>p<0.05 compared to vehicle-treated OVA-sensitized mic...
<p>a) <i>In vivo</i> responses, measuring change in airway resistance (saline, ovalbumin n = 12, 8 r...
<p>. (A) Enhanced pause (Penh) in response to 15 mg/ml of methacholine was measured in A/J, C57BL/6J...
<p>(A) Changes in lung resistance (R<sub>L</sub>) were recorded for 3 min after challenge with aeros...
<p>A) Bronchial hyperresponsiveness (BHR) to methacholine was determined at Day 75 in unrestrained c...
Many chronic human lung diseases have their origin in early childhood, yet most murine models used t...
<p>Bmpr2 ΔE2 mice developed more severe airway respiratory resistance to methacholine after 20 weeks...
<p><b>Copyright information:</b></p><p>Taken from "induces a sustained airway hyperresponsiveness an...
<p>Airway resistance was determined in anesthetized and ventilated mice using a Buxco plethysmograph...
<p>(A) Lung sections stained with periodic acid-Schiff (PAS) and elastic van Gieson's (EVG) stains. ...
<p>After last OVA challenge, mice were exposed to a series of incremental dosages of methacholine (6...
<p>WT or JH<sup>-/-</sup> mice were intranasally exposed to OAAH or PBS for 2 weeks, as described in...
<p>The airway resistance (R), after increasing concentrations of methacholine (0–10 mg/ml), was meas...
<p>Mice with OVA-induced EAB (EAB-Mice), with/without treatment with sPLA<sub>2</sub> inhibitor (EAB...
<p>(A) Log<sub>2</sub>(Penh) response curve to increasing doses of methacholine in A/J, C57BL/6J, Bc...
a<p>Inhalation, <sup>b</sup> Intranasal</p>*<p>p<0.05 compared to vehicle-treated OVA-sensitized mic...
<p>a) <i>In vivo</i> responses, measuring change in airway resistance (saline, ovalbumin n = 12, 8 r...
<p>. (A) Enhanced pause (Penh) in response to 15 mg/ml of methacholine was measured in A/J, C57BL/6J...
<p>(A) Changes in lung resistance (R<sub>L</sub>) were recorded for 3 min after challenge with aeros...
<p>A) Bronchial hyperresponsiveness (BHR) to methacholine was determined at Day 75 in unrestrained c...
Many chronic human lung diseases have their origin in early childhood, yet most murine models used t...
<p>Bmpr2 ΔE2 mice developed more severe airway respiratory resistance to methacholine after 20 weeks...
<p><b>Copyright information:</b></p><p>Taken from "induces a sustained airway hyperresponsiveness an...
<p>Airway resistance was determined in anesthetized and ventilated mice using a Buxco plethysmograph...
<p>(A) Lung sections stained with periodic acid-Schiff (PAS) and elastic van Gieson's (EVG) stains. ...
<p>After last OVA challenge, mice were exposed to a series of incremental dosages of methacholine (6...
<p>WT or JH<sup>-/-</sup> mice were intranasally exposed to OAAH or PBS for 2 weeks, as described in...